Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-03-28
2008-12-02
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S015000, C546S018000
Reexamination Certificate
active
07459462
ABSTRACT:
The invention relates to novel fredericamycin derivatives, to medicaments containing these derivatives or salts thereof, and to the use of fredericamycin derivatives for treating diseases, particularly tumor diseases.
REFERENCES:
patent: 4584377 (1986-04-01), Yokoi et al.
patent: 4673678 (1987-06-01), Misra
patent: 5166208 (1992-11-01), Kelly et al.
Latham, M.D., et al., “Inhibition of topoisomerases by fredericamycin A”, Cancer Chemotherapy and Pharmacology 24:167-171 (1989).
Abel Ulrich
Simon Werner
Aulakh Charanjit S.
Biofrontera Discovery GmbH
Connolly Bove & Lodge & Hutz LLP
LandOfFree
Fredericamycin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fredericamycin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fredericamycin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4031287